Upendra Argikar

Upendra Argikar is an experienced professional in the field of pharmaceuticals and medicinal chemistry, currently serving as an Editorial Board Member for Xenobiotica and Current Drug Metabolism. With a background that includes roles such as Investigator, Senior Investigator, Group Leader, and Section Head at Novartis from 2006 to 2021, Upendra has also held significant positions as the DMPK Leader at Gates Medical Research Institute since 2021 and as an editorial board member for various scientific publications, including Drug Metabolism and Disposition and Drug Metabolism Letters. Educational qualifications include a Doctor of Philosophy in Medicinal Chemistry from the University of Minnesota and a Bachelor of Pharmacy in Pharmaceutical Sciences from the University of Mumbai.